Total participants | 358 | |
Age (mean, SD) | 57.13 | 14.43 |
Sex (n, %) | ||
Male | 199 | 55.6% |
Female | 159 | 44.4% |
Race/ethnicity (n, %) | ||
Black or African American | 20 | 5.6% |
White | 317 | 88.5% |
Hispanic | 28 | 7.8% |
Others | 21 | 5.9% |
Respiratory diseases (n, %) | ||
COPD | 21 | 5.9% |
Home oxygen use | 0 | 0.0% |
Asthma | 37 | 10.3% |
Daily inhaled corticosteroids | 10 | 2.8% |
Albuterol, PRN, or daily | 28 | 7.8% |
Restrictive lung disease | 3 | 0.8% |
OSA (n, %) | 55 | 15.4% |
Stop BANG score recorded (n, %) | 334 | 93.3% |
Snore | 109 | 32.6% |
Tired during day | 70 | 21.0% |
Stop breathing while sleeping | 46 | 13.8% |
Hypertension | 174 | 52.1% |
Total score (n, %) | ||
0 | 103 | 30.8% |
1 | 122 | 36.5% |
2 | 62 | 18.6% |
3–4 | 47 | 14.1% |
Tobacco Hx (n, %) | ||
Never | 159 | 44.4% |
Current | 41 | 11.5% |
Previous | 158 | 44.1% |
Congestive heart failure (n, %) | 10 | 2.8% |
Hypertension (n, %) | 180 | 50.3% |
Diabetes (n, %) | 52 | 14.5% |
GFR < 60 (n, %) | 58 | 16.2% |
Chronic opioid use (n, %) | 42 | 11.7% |
Functional status (n, %)a | ||
< 4 METS | 2 | 0.6% |
≥ 4 METS | 315 | 88.0% |
Limited by pain/disability | 41 | 11.5% |